NEOTIGASON 25mg Price

Overview

Welcome to Dwaey, specifically on NEOTIGASON 25mg Capsules (Hard Gelatin) page.
This medicine contains an important and useful components, as it consists of Acitretin.
NEOTIGASON 25mg is available in the market in concentration 25mg/Capsule and in the form of Capsules (Hard Gelatin).

ACTAVIS HF is the producer of NEOTIGASON 25mg and it is imported from ICELAND, The most popular alternatives of NEOTIGASON 25mg are listed downward .

Mode Of Action

Acitretin is an active metabolite of etretinate but its mechanism of action is unknown.

Indication

• Lichen planus
• Psoriasis
• Congenital icthyosis
• Darier's disease

Precaution

Female patients to avoid alcohol during and 2 mth after treatment. Avoid blood donation during therapy or at least 1-3 yr after stopping therapy. Children. Radiographic treatment for prolonged therapy. Therapy should not last >6 mth. Monitor plasma lipid and glucose levels (especially diabetics) regularly. Monitor LFTs. Lactation: enters breast milk/not recommended.

Side Effects

• Cheilitis (>75%)
• Alopecia (50-75%)
• Hypertriglyceridemia (50-75%)
• Skin peeling (50-75%)
• Dry skin (25-50%)
• Dysglycemia (25-50%)
• Increased LFT (25-50%)
• Nail disorder (25-50%)
• Pruritus (25-50%)
• Rhinitis (25-50%)
• Arthralgia (10-25%)
• Changes in phosphorus
• potassium
• sodium
• & magnesium levels (10-25%)
• Dry mouth (10-25%)
• Epistaxis (10-25%)
• Erythematous rash (10-25%)
• Hepatotoxicity (10-25%)
• Hyperesthesia (10-25%)
• Paresthesia (10-25%)
• Paronychia (10-25%)
• Rigors (10-25%)
• Skin atrophy (10-25%)
• Spinal hyperostosis (10-25%)
• Sticky skin (10-25%)
• Xerophthalmia (10-25%) 1-10% Edema
• Flushing
• Depression
• Fatigue
• Headache
• Insomnia
• Somnolence
• Abdominal pain
• Anorexia
• Diarrhea
• Gingivitis
• Increased appetite
• Nausea
• Stomatitis
• Vomiting
• Hot flashes
• Vision changes
• Corneal epithelial abnormality
• Sinusitis Potentially Fatal: Phototoxicity
• jaundice
• hepatitis and hepatotoxity.

Contra indication

Pregnancy (before the start, during and at least 2-3 yr after cessation of therapy), lactation. Hepatic and renal impairment. Hyperlipidaemia.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.